Akebia Therapeutics Inc. buy StockNews.com
Start price
20.04.24
/
50%
€1.28
Target price
20.04.25
-
Performance (%)
36.64%
End price
21.04.25
€1.75
Summary
This prediction ended on 21.04.25 with a price of €1.75. With a performance of 36.64% the BUY prediction by StockNews_com was a big success. StockNews_com has a follow-up prediction for Akebia Therapeutics Inc., but this time predicts that Akebia Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 7.453% | 7.453% | -20.505% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by StockNews_com for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten